Actuate Therapeutics Inc., Dublin, IE

https://www.actuatetherapeutics.com

Actuate is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for high impact cancers and inflammatory diseases. Actuate’s lead drug, elraglusib (a novel GSK-3 inhibitor), targets molecular pathways in cancer that are involved in promoting tumor growth and resistance to conventional cancer drugs such as chemotherapy. Elraglusib is also emerging as a mediator of anti-tumor immunity through the inhibition of multiple immune checkpoints and the regulation of immune cell function. *

	Start	2023-02-23 existent
	Group	Actuate Therapeutics Inc.
	Today	Actuate Therapeutics Inc.
	Industry	drug development

	Region	Dublin
	Country	Ireland, Republic of
	Street	St. Mary’s Place The Black Church
	City	D07 P4AX Dublin
		Address record changed: 2023-03-03

Basic data	Employees	n. a.

		* Document for »About Section«: Tempus Labs, Inc.. (2/23/23). "Press Release: Tempus Announces New Multi-omics Collaboration with Actuate Therapeutics".

		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]